Human stem cell aging: do mitochondrial DNA mutations have a causal role? by Baines HL et al.
 Newcastle University ePrints 
 
Baines HL, Turnbull DM, Greaves LC. Human stem cell aging: do 
mitochondrial DNA mutations have a causal role?. Aging Cell 2014, 13(2), 
201-205. 
Copyright: 
© 2014 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. 
This is an open access article under the terms of the Creative Commons Attribution License, which 
permits use, distribution and reproduction in any medium, provided the original work is properly cited. 
DOI link to article: 
http://dx.doi.org/10.1111/acel.12199 
 
Date deposited:  21 May 2014 
 
 
 
This work is licensed under a Creative Commons Attribution 3.0 Unported License 
 
 ePrints – Newcastle University ePrints 
http://eprint.ncl.ac.uk 
 
REVIEW
Human stem cell aging: do mitochondrial DNA mutations have a
causal role?
Holly L. Baines,1 Douglass M. Turnbull1,2 and Laura C.
Greaves1
1Centre for Brain Ageing and Vitality, Institute for Ageing and Health,
The Medical School, Newcastle upon Tyne, NE2 4HH, UK
2Wellcome Trust centre for Mitochondrial Research, Institute for Ageing and
Health, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK
Summary
A decline in the replicative and regenerative capacity of adult
stem cell populations is a major contributor to the aging process.
Mitochondrial DNA (mtDNA) mutations clonally expand with age
in human stem cell compartments including the colon, small
intestine, and stomach, and result in respiratory chain deficiency.
Studies in a mouse model with high levels of mtDNA mutations
due to a defect in the proofreading domain of the mtDNA
polymerase c (mtDNA mutator mice) have established causal
relationships between the accumulation of mtDNA point muta-
tions, stem cell dysfunction, and premature aging. These mtDNA
mutator mice have also highlighted that the consequences of
mtDNA mutations upon stem cells vary depending on the tissue.
In this review, we present evidence that these studies in mice are
relevant to normal human stem cell aging and we explore
different hypotheses to explain the tissue-specific consequences
of mtDNA mutations. In addition, we emphasize the need for a
comprehensive analysis of mtDNA mutations and their effects on
cellular function in different aging human stem cell populations.
Key words: aging; human; mitochondria; mutator mouse;
stem cells.
Introduction
Stem cell aging
Aging is a stochastic process characterized by a decline in the
homeostatic and regenerative processes within tissues (Kirkwood,
2005). Common features of aging such as decreased wound healing
in the skin, decreased immunity, hair greying, and hair loss all result from
reduced tissue homeostasis and regeneration with age, due to dimin-
ished somatic stem cell function (Sharpless & DePinho, 2007).
Under normal conditions, stem cells divide asymmetrically to give
another stem cell for self-renewal and one daughter cell that
differentiates into an effector/progenitor cell (Liu & Rando, 2011) to
maintain normal tissue function. As we age, stem cells incur damage due
to features of both chronological and replicative aging, especially stem
cells in rapidly replicating tissues such as the gut, skin, and blood (Liu &
Rando, 2011). In some replicating tissues, this causes depletion in the
stem cell pool, either due to replicative senescence or a decline in the
self-renewal capacity, commonly seen in neural stem cells (Maslov et al.,
2004) and melanocyte stem cells (Nishimura et al., 2005). Alternatively,
stem cells may undergo malignant transformation, increasing the risk of
cancer with age (Liu & Rando, 2011). However, in the majority of cases,
stem cells endure alterations in their normal fate and function of their
progeny due to disturbances in differentiation, as seen in hematopoietic
stem cells (HSCs) (Rossi et al., 2005). Understanding the molecular
mechanisms responsible for such age-related changes in normal fate and
function of adult stem cell populations is important if we ever aim to
deter tissue degeneration, prolong regeneration, and improve healthy
aging.
Damage to the mitochondrial DNA (mtDNA) resulting in respiratory
chain dysfunction has been proposed to be a significant contributor to
the aging phenotype (Linnane et al., 1989). Numerous studies present
evidence for a relationship between mtDNA defects and human stem cell
aging (Taylor et al., 2003; McDonald et al., 2008; Fellous et al., 2009);
however, this data may just be circumstantial and mtDNA defects could
merely be a biomarker of the aging process. Here, we discuss the
significance of mtDNA point mutations and respiratory chain deficiency
in aging human mitotic tissues and evaluate studies performed in the
mtDNA mutator mouse to determine a causal role for mitochondria in
normal stem cell aging.
Mitochondria
Mitochondria are dynamic, intracellular organelles that primarily function
to generate ATP by the process of oxidative phosphorylation. The
mitochondrial genome is the only extra nuclear source of DNA within a
cell and is a covalently closed, 16 596 base pair molecule, encoding 37
genes including 13 essential subunits of the respiratory chain, 2 rRNAs
(12s and 16s), and 22 tRNAs (Anderson et al., 1981).
Mitochondria and aging
The mitochondrial theory of aging is based upon the principle that
somatic mutations in mtDNA accumulate throughout life and result in
reduced mitochondrial and respiratory chain function (Miquel et al.,
1980). Tissue dysfunction subsequently arises from defects in energy
metabolism, apoptosis, and senescence, eventually leading to age-
related frailty and disease (Taylor & Turnbull, 2005). The mitochondrial
free radical theory of aging suggests that this activates a vicious cycle,
whereby dysfunction of the oxidative phosphorylation system causes
enhanced ROS production and further damage to mtDNA, leading to the
progressive accumulation of somatic mtDNA mutations with age and
further oxidative damage, eventually resulting in cell death (Harman,
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1972). However, there is much controversy surrounding the mitochon-
drial free radical theory of aging, as long-lived species do not always
demonstrate lower levels of ROS (Chen et al., 2007) and long-lived
mammals, such as the naked mole rat, demonstrate fairly high levels of
ROS and high levels of oxidative damage to lipids, DNA, and proteins
(Andziak et al., 2006). Moreover, there is no evidence to suggest that
the incidence of oxidative damage to mtDNA is greater than nuclear
DNA (Lim et al., 2005).
Alternatively, it has been proposed that mtDNA mutations are
principally induced by replication errors mediated by mtDNA polymerase
Y (Zheng et al., 2006). Data from computational models (Elson et al.,
2001) and mitochondrial mutation assays (Coller et al., 2005) suggest
that such replication errors arise during early development, accumulating
throughout life by the mechanism of clonal expansion and random
genetic drift (Elson et al., 2001). Given the multicopy nature of mtDNA
within cells, most point mutations are highly recessive and it is only when
a point mutation clonally expands and reaches a critical threshold level
that a respiratory chain defect is observed. This threshold differs
according to the type of mtDNA mutation but is generally ~60% for
deleted mtDNA (Sciacco et al., 1994) and ~85% for point mutations
(Boulet et al., 1992). This defect can be readily identified by the absence
of histochemical staining for cytochrome c oxidase (COX) (Old &
Johnson, 1989).
Somatic MtDNA mutations in aging human mitotic
tissues
MtDNA mutations were initially detected in aging human postmitotic
tissues, with a mosaic pattern of COX deficiency seen in the heart
(Muller-Hocker, 1989), muscle (Muller-Hocker, 1990), and brain (Cottrell
et al., 2001). More recently, respiratory chain defects have been shown
to accumulate to significant levels in aging human mitotic tissues,
including the colon (Taylor et al., 2003), liver, pancreas (Fellous et al.,
2009), stomach (McDonald et al., 2008), and small intestine (Gutierrez-
Gonzalez et al., 2009). Analysis of single COX-deficient cells in these
studies revealed that the cellular defect was directly caused by clonally
expanded somatic mtDNA point mutations. In the human colon, COX-
deficient crypts are rarely detected below the age of 30 (Taylor et al.,
2003) and the majority of mtDNA point mutations identified are base
transitions, which are likely to be due to errors during mtDNA replication
(Greaves et al., 2012). This further supports the hypothesis that somatic
mtDNA mutations principally arise during early life and accumulate
throughout adulthood by clonal expansion (Elson et al., 2001; Coller
et al., 2005). Furthermore, in the aging, human colon somatic mtDNA
mutations occur at random and are commonly nonsynonymous or
frameshift mutations that are significantly more pathogenic than
germline variants (Greaves et al., 2012). This indicates an absence of
selective constraints, replication, and/or selective clonal expansion of
somatic mtDNA mutations in mitotic tissues. In mitotic tissues, the only
long-lived cells are the stem cells, and so, the mtDNA mutations must be
occurring and being fixed in these cells, strongly indicating a role for
mtDNA mutations in stem cell aging.
In the aging, human colon mtDNA mutations and respiratory chain
deficiency have been associated with an altered cellular phenotype
characterized by a decrease in crypt cell number and cell proliferation
(Nooteboom et al., 2010). However, this is the only study to have
explored the functional consequences of mitochondrial dysfunction in a
replicating human tissue as studies in human subjects are limited due to
the availability of human tissue samples and a lack of robust stem cell
markers. Therefore, it remains largely unknown how mtDNA defects
contribute to human stem cell aging.
Use of animal models
To explore the potential role of mtDNA point mutations in aging, it is
therefore necessary to use animal models. The development of the
mtDNA mutator mouse provided definitive evidence for a causal
relationship between mtDNA mutations and aging. These mice have a
homozygous mutation (D257A) in the proofreading domain of mtDNA
polymerase c, significantly reducing its proofreading activity and
resulting in the accelerated accumulation of mtDNA mutations and
severe respiratory chain deficiency (Trifunovic et al., 2004; Kujoth et al.,
2005). MtDNA mutator mice display a reduced lifespan and a premature
aging phenotype, which closely resembles normal human aging and is
characterized by kyphosis, reduced subcutaneous fat, hair loss, weight
loss, anemia, osteoporosis, reduced fertility, and enlargement of the
heart (Trifunovic et al., 2004; Kujoth et al., 2005).
Premature aging is driven by stem cell dysfunction in mtDNA
mutator mice
Somatic mtDNA mutations in the mtDNA mutator mice arise from
replication errors during development (Ameur et al., 2011), and a
number of studies have shown that this causes early-onset stem cell
dysfunction, which drives the tissue-specific aging phenotypes in these
mice.
Abnormalities in stem cell populations in the mtDNA mutator mice
vary significantly depending on the tissue; with some displaying a direct
effect upon the stem cell pool and others demonstrating effects on
downstream differentiation events and early precursors. In the hema-
topoietic system of mtDNA mutator mice, mtDNA mutations induce
blocks in early differentiation events and cause abnormalities in
downstream hematopoietic progenitor cells, but have no direct effect
on the hematopoietic stem cell (HSC) pool (Norddahl et al., 2011). The
impaired differentiation and resulting abnormal myeloid lineages are
directly associated with anemia and lymphopenia in the mtDNA mutator
mice, which are the principal driving factors of premature aging in these
animals (Ahlqvist et al., 2012). By comparison, abnormalities in neural
stem cells show a direct effect upon stem cell function, distinguished by
a decline in the number of quiescent stem cells and a decrease in their
self-renewal capacity in response to mtDNA mutation accumulation
(Ahlqvist et al., 2012). Studies of the epithelial crypt cells in the small
intestine of mtDNA mutator mice demonstrated increased levels of
apoptosis, a decrease in the number of proliferating cells, and impaired
development of stem cell-derived organoids in vitro (Fox et al., 2012).
These abnormalities corresponded with the loss of respiratory chain
activity and contributed to reduced absorption of dietary lipids in the gut
(Fox et al., 2012).
Taken together, these studies indicate that aging is driven by stem cell
dysfunction in response to the accumulation of mtDNA point mutations.
However, it still remains unknown exactly how mtDNA point mutations
cause stem cell dysfunction and moreover why we see tissue-specific
alterations in either the stem cells directly or stem cell fate and
downstream differentiation events? We know that there are different
cell fates for damaged stem cells; however, we do not know what
determines whether a damaged stem cell will undergo cell death,
senescence, or malignant transformation in response to mtDNA
mutations.
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Proposed mechanisms for the effect of somatic mtDNA
mutations on stem cell function
One plausible explanation is the individual stem cell niche and
microenvironment. The maintenance of somatic stem cells relies upon
a balance between self-renewal and differentiation, which is regulated
partly by signaling and physiological ROS molecules (Hamanaka and
Chandel, 2010). Alterations in ROS signaling have major effects upon
the quiescent/active state of stem cell populations causing shifts in
proliferation or differentiation, particularly in HSCs (Shao et al., 2011). In
mtDNA mutator mice, the abnormal phenotypes observed in neural stem
cells and hematopoietic progenitor cells were rescued by supplementa-
tion with the antioxidant N-acetyl-L-cysteine (Ahlqvist et al., 2012). This
implies that mtDNA mutations can cause slight alterations in redox status
to which stem cells are highly sensitive to, thus affecting their capacity
for regeneration and reconstitution (Ahlqvist et al., 2012). It is worth
acknowledging that N-acetyl-L-cysteine is a widely used pharmaceutical
and is involved in numerous physiological processes other than just ROS
scavenging, some of which include modulating cell proliferation,
regulating the immune response and metabolism of prostaglandins
and leukotrienes (Samuni et al., 2013). Thus, N-acetyl-L-cysteine treat-
ment could have reversed the abnormal stem cell phenotypes in the
mtDNA mutator mice by affecting other physiological mechanisms other
than just redox status. Nevertheless, it is highly plausible that mtDNA
mutations may cause mild alterations in ROS signaling and that it is the
specific stem cell niche and whether or not the stem cells are in an active
or quiescent state that determines how a stem cell will respond to the
change in redox status and the subsequent change in cell fate and tissue-
specific dysfunction (Fig. 1). For example in the gut, a highly proliferative
tissue, the stem cells are fairly active and so alterations in ROS signaling
are likely to affect proliferation events, as seen in the mtDNA mutator
mouse (Fox et al., 2012). This is in contrast to the hematopoietic system
where HSCs are maintained in a fairly dormant/quiescent state (Shao
et al., 2011) and changes in ROS signaling may only take effect at the
point of stem cell activation and differentiation, as seen in the mtDNA
mutator mice (Norddahl et al., 2011; Ahlqvist et al., 2012).
Alternatively, mtDNA mutations may not directly affect stem cell
function but may only act at the point of early stem cell differentiation,
leading to the production of abnormal progeny cells and a loss of
somatic tissue maintenance (Fig. 1). In mtDNA mutator mice, mtDNA
point mutations were found to affect hematopoietic progenitor cells
during differentiation, and HSCs remained unaffected despite presenting
with the same level of mtDNA mutations (Norddahl et al., 2011; Ahlqvist
et al., 2012). Evidence suggests that somatic stem cells may be quite
resistant to mitochondrial dysfunction as they are maintained in a fairly
dormant/quiescent state, contain few mitochondria, and rely more on
glycolysis for energy production than oxidative metabolism (Simsek
et al., 2010; Shao et al., 2011). It is only during differentiation that
mitochondrial content and ATP levels increase, suggesting that oxidative
phosphorylation plays only a minor role in quiescent stem cells and self-
renewal, but downstream progenitors require intact mitochondrial
function (Inoue et al., 2010). Thus, it may be the tissue-specific
differentiation processes of stem cells and the sensitivity of progeny
cells that govern the different aging phenotypes caused by mtDNA point
mutations.
Concluding remarks
In this review, we have presented evidence that somatic mtDNA
mutations and respiratory chain deficiency accumulate to significant
levels in aging human replicative tissues, and evidence from the mtDNA
mutator mice demonstrates that mtDNA mutations directly cause stem
cell dysfunction and induce age-related phenotypes. It has been shown
that somatic mutagenesis is influenced by pre-existing germline mtDNA
mutations in mice that can accelerate the clonal expansion of somatic
mtDNA mutations and have life-long consequences, causing certain
features of premature aging (Ross et al., 2013). Low-level heteroplasmic
mtDNA mutations are also commonly inherited through the female
germline in humans (Li et al., 2010; Payne et al., 2013) and are thus
likely to aggravate somatic mutagenesis and the aging process in
subsequent generations.
Studies in the mtDNA mutator mice have also highlighted the
importance of interactions between the nuclear and mitochondrial
genome, when considering the role of somatic mtDNA mutations in
aging. In the two strains of mtDNA mutator mice, the different nuclear
backgrounds appear to play a significant role in the severity of the
premature aging phenotypes, the levels of COX deficiency detected in
tissues (H.L. Baines & L.C. Greaves, unpublished data from our lab), and
lifespan, with the European strain (C57Bl/6N background) (Trifunovic
et al., 2004) displaying a more severe phenotype than the American
strain (C57Bl/6J background) (Kujoth et al., 2005). Thus, it is likely that
variation between human nuclear genomes will influence the effects and
extent to which somatic mtDNA mutations and mitochondrial dysfunc-
tion play a role in tissue dysfunction and aging.
While the incidence of mitochondrial dysfunction is higher in the
mtDNA mutator mice than in normal human aging, the development
and types of mtDNA mutation, the clonal expansion, and the respiratory
chain deficiency are similar. Thus, somatic mtDNA mutations are likely to
Fig. 1 Schematic diagram hypothesizing the possible mechanisms by which
mtDNA point mutations may affect stem cell function and drive aging phenotypes.
MtDNA mutations arise in stem cells during early development due to errors during
mtDNA replication and accumulate throughout life by clonal expansion. Upon
reaching a critical threshold level, mtDNA mutations may cause slight alterations in
ROS signaling, affecting the quiescent state of stem cells and their capacity for
regeneration and reconstitution. Depending on the active/quiescent state of stem
cells, this may either lead to aberrant proliferation and malignant transformation or
may cause depletion in the stem cell pool and a subsequent decline in tissue
function. Alternatively, mtDNA mutations may have no direct effect upon the stem
cells but may instead act at the point of early differentiation, causing
differentiation blocks and the production of abnormal progeny cells, contributing
to a loss of normal tissue homeostasis and age-related dysfunction.
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contribute to stem cell dysfunction and age-related phenotypes in a
similar manner in normal human aging, but to a lesser effect.
Nevertheless, in mtDNA mutator mice, aging is driven solely by mtDNA
mutations, whereas normal human aging is a complex, multifactorial
process driven by multiple molecular mechanisms including not only
mtDNA defects but also ROS, senescence, and damaged proteins.
To truly understand the role of mtDNA point mutations in human
stem cell aging, future research should focus on establishing a
comprehensive overview of clonally expanded mtDNA point mutations
and respiratory chain deficiency in all aging human replicative tissues, in
particular concentrating on any associated changes in markers of stem
cell function such as proliferation, differentiation, and self-renewal.
Furthermore, studies should be performed in replicative tissues of
mitochondrial disease patients with different mtDNA point mutations as
this would have profound implications for our understanding of
mutation and tissue-specific effects in stem cell compartments. Only
then will we be able to determine the consequences and contribution of
mtDNA defects in stem cell aging and how this may influence the human
aging phenotype as a whole.
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